(Q39675616)
Statements
1 reference
Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer (English)
1 reference
Frédéric Courbon
1 reference
Sébastien Vergez
1 reference
Jean-Pierre Delord
1 reference
Fabienne Thomas
1 reference
Philippe Rochaix
1 reference
Olivier Caselles
1 reference
Thomas Filleron
1 reference
Séverine Brillouet
1 reference
Pierre Canal
1 reference
Ben C Allal
1 reference
26 July 2010
1 reference
1 reference
16
1 reference
17
1 reference
4434-4445
1 reference
Identifiers
1 reference
1 reference